Target intelligence / Profile preview

RNA, U6 small nuclear 110, pseudogene (RNU6-110P)

Target
RNU6-110P
Molecular classification
Other, processed pseudogene, non-coding RNA pseudogene
01

Overview

RNU6-110P, or RNA, U6 small nuclear 110, pseudogene, is a processed pseudogene that shares sequence similarity with the functional U6 small nuclear RNA (snRNA) gene[4][5]. The canonical U6 snRNA is a key component of the spliceosome, a nuclear ribonucleoprotein complex essential for removing introns from pre-mRNA during splicing[1][3]. However, RNU6-110P itself is a non-functional genomic copy that has arisen through retrotransposition mechanisms such as LINE-1 (L1) activity, resulting in an RNA-derived pseudogene that does not encode a functional RNA or protein product[5]. Pseudogenes like RNU6-110P are generally not transcribed or, if transcribed, do not produce functionally relevant RNAs. They are not considered therapeutic or biological targets and do not play a direct role in disease or serve as biomarkers or drug interaction partners[5]. Note: - RNU6-110P is a pseudogene, meaning it does not produce a functional RNA or protein and is not considered a therapeutic target. - The entry is not a genuine molecular target and should be flagged as potentially incorrect or irrelevant for drug or therapeutic development purposes[5][4]. If you need information on the functional form, refer to "U6 small nuclear RNA" (not the pseudogene), which is directly involved in pre-mRNA splicing[1][3].

Other names
RNU6-110P

Beyond the preview

Go deeper on RNA, U6 small nuclear 110, pseudogene (RNU6-110P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 110, pseudogene (RNU6-110P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call